Perspective Therapeutics, Inc. (CATX)

3.13 +0.01 (+0.32%) USD  |  NYAM  |  Sep 04, 16:00
3.145 +0.02 (+0.48%) After-Hours: 20:00
More

Perspective Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for CATX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Annual Revenue Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2028 --
December 31, 2027 --
December 31, 2026 --
Date Value
December 31, 2025 --
December 31, 2024 --

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Anika Therapeutics, Inc. Upgrade
MiMedx Group, Inc. Upgrade
ABVC BioPharma, Inc. Upgrade
Enovis Corp. Upgrade
Edwards Lifesciences Corp. Upgrade